{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-129823","form_type":"8-K","ticker":"NVAX","cik":"0001000694","company_name":"NOVAVAX INC","filed_at":"2024-12-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.288790+00:00","generated_at":"2026-05-29T01:54:09.733736+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Novavax amends Australia COVID vaccine agreement; cancels doses, credits $31M, extends to 2029","bullets":["Amendment #5 cancels certain COVID vaccine doses scheduled for delivery Q4 2023 through Q4 2025.","Approximately $31M of advanced payment credited against outstanding invoices and future delivery of ~3M doses.","Updated delivery schedule allows potential delivery of vaccine through end of 2029.","Commonwealth granted remedies for missed deliveries, regulatory approval failures, or notification lapses.","No additional cash payments required for future doses under the amendment."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-129823","json":"https://secwatch.observer/filing/0001104659-24-129823.json","markdown":"https://secwatch.observer/filing/0001104659-24-129823.md","text":"https://secwatch.observer/filing/0001104659-24-129823.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924129823/0001104659-24-129823-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924129823/tm2431398d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T01:54:09.733736+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}